You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Frequency Basal Cell Carcinomas

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Enrolling by invitation
  • Basal Cell Carcinoma
  • Gorlin Syndrome
  • Active surveillance
  • Oslo, Norway
    Oslo University Hospital
Jun 8, 2023

Recurrent Basal Cell Carcinoma Trial in United States (Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle)

Terminated
  • Recurrent Basal Cell Carcinoma
  • Patidegib Topical Gel, 2%
  • Patidegib Topical Gel, Vehicle
  • Apple Valley, California
  • +13 more
May 25, 2021

Gorlin Syndrome Trial (Patidegib Topical Gel, Vehicle Gel)

Not yet recruiting
  • Gorlin Syndrome
  • Patidegib Topical Gel
  • Vehicle Gel
  • (no location specified)
Sep 15, 2023

HRQoL Keratinocyte Carcinomas

Enrolling by invitation
  • Basal Cell Carcinoma
  • +2 more
  • questionnaires
  • Ghent, Belgium
  • +1 more
Jan 25, 2023

Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil

Recruiting
  • Superficial Basal Cell Carcinoma
  • Squamous Cell Carcinoma in Situ
  • Combination cream of 5-fluorouracil and calcipotriene
  • 5-fluorouracil cream
  • Boston, Massachusetts
    Boston Medical Center Dermatology Clinic
Nov 9, 2022

Pathological Characteristics of Basal Cell Carcinoma

Recruiting
  • Dermatological Tumors
  • Excision
  • Cairo, Egypt
    Abdulkarim Hasan
Jul 18, 2022

Basal Cell Carcinoma Trial in Wroclaw (TOOsonix System ONE-M)

Recruiting
  • Basal Cell Carcinoma
  • TOOsonix System ONE-M
  • Wrocław, Poland
    Old Town Clinic
Jan 31, 2023

Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)

Recruiting
  • Basal Cell Carcinoma
  • Basal Cell Nevus Syndrome
  • ASN-002
  • Brisbane, Queensland, Australia
  • +5 more
Feb 10, 2022

Carcinoma, Basal Cell Trial in Copenhagen, Roskilde (TOOsonix system ONE-M)

Recruiting
  • Carcinoma, Basal Cell
  • TOOsonix system ONE-M
  • Copenhagen, Hovedstaden, Denmark
  • +1 more
Mar 21, 2022

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)

Not yet recruiting
  • Basal Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma
  • FLASH RT
  • Conventional RT
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023

Basal Cell Carcinoma Trial in Copenhagen (Calcium chloride)

Recruiting
  • Basal Cell Carcinoma
  • Calcium chloride
  • Copenhagen, Denmark
    Department of Dermatology, Bispebjerg Hospital
Sep 8, 2021

Basal Cell Carcinoma in Basal Cell Nevus Syndrome Trial in Portland (ASN-002)

Suspended
  • Basal Cell Carcinoma in Basal Cell Nevus Syndrome
  • ASN-002
  • Portland, Oregon
    OHSU
Oct 6, 2021

Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer Trial in North Sydney (drug, procedure, other)

Recruiting
  • Basal Cell Carcinoma
  • +3 more
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Jun 9, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • sEphB4-HSA with chemotherapy
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 9, 2022

Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)

Recruiting
  • Locally Advanced Basal Cell Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Aug 3, 2022

HPV in Sinonasal Ca: Retrospective Analysis Association of Human

Recruiting
  • Sinonasal Carcinoma
  • HPV-Related Squamous Cell Carcinoma
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 28, 2022

    3 in Vivo Microscopic Imaging Techniques for Diagnosis of

    Completed
    • Basal Cell Carcinoma
    • +5 more
    • Fluorescence-Advanced videodermatoscopy
    • +2 more
    • Saint Etienne, France
      Chu de Saint Etienne
    Sep 14, 2023

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    BCCs in Gorlin Syndrome Patients Trial in United Kingdom, United States (PTX-022, Vehicle comparator)

    Recruiting
    • BCCs in Gorlin Syndrome Patients
    • Scottsdale, Arizona
    • +15 more
    May 5, 2022

    Decisional Conflicts, Health-related QoL and Satisfaction With

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +9 more
    • Regular care with additionally administration of questionnaires
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Jul 28, 2022

    Field Actinic Keratoses, Basal Cell Carcinoma, Bowen's Disease Trial (Metvix (methyl aminolevulinate))

    No longer available
    • Field Actinic Keratoses
    • +2 more
    • Metvix (methyl aminolevulinate)
    • (no location specified)
    Feb 16, 2021

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • Rochester, New York
      University of Rochester
    Feb 7, 2022

    Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

    Recruiting
    • Lung Small Cell Carcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021

    Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

    Recruiting
    • Microsatellite High Cancers
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 8, 2022